BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32647651)

  • 1. 15-Deoxy-Δ
    Na HK; Yang H; Surh YJ
    J Cancer Prev; 2020 Jun; 25(2):100-110. PubMed ID: 32647651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-Deoxy-Δ
    Kim SJ; Cho NC; Han B; Kim K; Hahn YI; Kim KP; Suh YG; Choi BY; Na HK; Surh YJ
    FEBS Lett; 2021 Mar; 595(5):604-622. PubMed ID: 33452674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
    Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Deoxy-Δ
    Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ
    Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 as a Potential Target for Tumor Suppressive Effects of 15-Deoxy-Δ
    Kim SJ; Cho NC; Hahn YI; Kim SH; Fang X; Surh YJ
    J Cancer Prev; 2021 Sep; 26(3):207-217. PubMed ID: 34703823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S; Rattan R; Singh AK; Singh I
    J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxy-Δ
    Choi J; Suh JY; Kim DH; Na HK; Surh YJ
    J Cancer Prev; 2020 Sep; 25(3):152-163. PubMed ID: 33033709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
    Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-Deoxy-Δ12,14-prostaglandin J2 induces PPARγ- and p53-independent apoptosis in rabbit synovial cells.
    Sakaba Y; Awata H; Morisugi T; Kawakami T; Sakudo A; Tanaka Y
    Prostaglandins Other Lipid Mediat; 2014 Jun; 109-111():1-13. PubMed ID: 24680891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Deoxy-Δ
    Choi JE; Kim JH; Song NY; Suh J; Kim DH; Kim SJ; Na HK; Nadas J; Dong Z; Cha YN; Surh YJ
    Free Radic Res; 2016 Oct; 50(10):1140-1152. PubMed ID: 27598034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages.
    Vunta H; Davis F; Palempalli UD; Bhat D; Arner RJ; Thompson JT; Peterson DG; Reddy CC; Prabhu KS
    J Biol Chem; 2007 Jun; 282(25):17964-17973. PubMed ID: 17439952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells.
    Lee SJ; Kim MS; Park JY; Woo JS; Kim YK
    Toxicology; 2008 Jun; 248(2-3):121-9. PubMed ID: 18450357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of 15-deoxy Δ
    Yamamoto Y; Yamamoto T; Koma H; Nishii A; Yagami T
    Biochem Biophys Rep; 2017 Mar; 9():61-66. PubMed ID: 28955990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-Deoxy-Δ
    Kim W; Lee HN; Jang JH; Kim SH; Lee YH; Hahn YI; Ngo HK; Choi Y; Joe Y; Chung HT; Chen Y; Cha YN; Surh YJ
    Antioxid Redox Signal; 2017 Dec; 27(17):1412-1431. PubMed ID: 28398824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS.
    Kim DH; Kim JH; Kim EH; Na HK; Cha YN; Chung JH; Surh YJ
    Carcinogenesis; 2009 Apr; 30(4):645-54. PubMed ID: 19136476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death.
    Koyani CN; Kitz K; Rossmann C; Bernhart E; Huber E; Trummer C; Windischhofer W; Sattler W; Malle E
    Biochem Pharmacol; 2016 Mar; 104():29-41. PubMed ID: 26801686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitive effects of 15-deoxy-Δ(12),(14)-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis.
    Chen K; Dai W; Wang F; Xia Y; Li J; Li S; Liu T; Zhang R; Wang J; Lu W; Zhou Y; Yin Q; Zheng Y; Abudumijiti H; Chen R; Lu J; Zhou Y; Guo C
    Onco Targets Ther; 2015; 8():3585-93. PubMed ID: 26664142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
    Ray DM; Akbiyik F; Phipps RP
    J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase.
    Yu X; Egner PA; Wakabayashi J; Wakabayashi N; Yamamoto M; Kensler TW
    J Biol Chem; 2006 Sep; 281(36):26245-52. PubMed ID: 16857669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ
    Reddy AT; Lakshmi SP; Banno A; Reddy RC
    ACS Chem Biol; 2018 Dec; 13(12):3269-3278. PubMed ID: 30398845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.